Detrol LA · DIN 02244612 · 2 mg · extended release capsule
Limited Use, Reason for Use code 290 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 290 required
Write on scriptReason for Use code 290 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 290
Reason for Use code 290
For patients with urinary frequency, urgency or urge incontinence who have:
Failed to respond to behavioral techniques AND an adequate trial of oxybutynin with gradual dose escalation has shown to be either ineffective or resulted in unacceptable side effects.
NOTE: If after a trial of 2 weeks patients continue to experience similar side effects and no greater efficacy than oxybutynin, continued therapy with this more costly agent should be reassessed.
Antimuscarinic agents should be used with caution in the elderly due to potentially serious adverse effects (e.g. confusion, psychosis, acute urinary retention, constipation). Antimuscarinic agents should be avoided in older adults with pre-existing cognitive impairment (e.g. dementia) and those who are already using other drugs with significant anticholinergic effects (e.g. tricyclic antidepressants) in order to avoid a high overall anticholinergic drug burden.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: RxHelp ONE lists Detrol LA (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Detrol LA · DIN 02244612
Manufacturer: Upjohn Canada ULC; listing date 2004-04-06
Health Canada: Marketed since 2023-05-29 · brand DETROL LA · ATC G04BD07 TOLTERODINE · form Capsule (extended-release) · route Oral · ingredients TOLTERODINE TARTRATE 2 MG · company Bgp pharma ulc · schedule Prescription
Ministry pays: $0.9822 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02244612)
Source record
DIN 02244612: Detrol LA
Raw flags: sec12=Y, sec3=Y
Item: 920000451; group id 973; item number 2306; lccId 00140; manufacturer id UJC
Source form: SR Cap; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.3698; ministry $0.9822
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02244612
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=68599
Interchangeable products
Sandoz Tolterodine LA · DIN 02413140 · $0.9822
Teva-Tolterodine LA · DIN 02412195 · $0.9822
Shortage status: not checked (no credentials)